XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 299.8 $ 289.2
Trade and other accounts receivable (less allowances of $9.6 million and $11.9 million respectively) 343.5 341.7
Inventories (less allowances of $35.8 million and $34.6 million respectively):    
Finished goods 216.4 197.9
Raw materials 99.0 103.1
Total inventories 315.4 301.0
Prepaid expenses 16.0 21.0
Prepaid income taxes 1.0 3.1
Other current assets 1.4 0.6
Total current assets 977.1 956.6
Net property, plant and equipment 277.1 269.7
Operating lease right-of-use assets 44.4 44.8
Goodwill 388.4 382.5
Other intangible assets 72.8 65.4
Deferred tax assets 8.6 9.4
Pension asset 1.2 2.4
Other non-current assets 5.0 3.9
Total assets 1,774.6 1,734.7
Current liabilities:    
Accounts payable 169.5 163.8
Accrued liabilities 147.5 169.1
Current portion of operating lease liabilities 14.0 13.9
Current portion of plant closure provisions 5.0 5.0
Accrued income taxes 21.6 19.6
Total current liabilities 357.6 371.4
Operating lease liabilities, net of current portion 30.4 31.0
Plant closure provisions, net of current portion 57.2 55.3
Deferred tax liabilities 23.0 23.5
Pension liabilities and post-employment benefits 12.9 13.1
Acquisition-related contingent consideration 22.6 20.1
Other non-current liabilities 5.2 4.2
Total liabilities 508.9 518.6
Equity:    
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares 0.3 0.3
Additional paid-in capital 370.7 369.9
Treasury stock (4,580,264 and 4,594,943 shares at cost, respectively) (96.5) (93.0)
Retained earnings 1,057.8 1,025.0
Accumulated other comprehensive loss (72.3) (91.0)
Total Innospec stockholders' equity 1,260.0 1,211.2
Non-controlling interest 5.7 4.9
Total equity 1,265.7 1,216.1
Total liabilities and equity $ 1,774.6 $ 1,734.7